TriSalus Life Sciences Inc. (TLSI NASDAQ) stock market data APIs
$6.7519
0.4(5.9%)
as of December 8, 2025
Try our APIs with
free plan!
TriSalus Life Sciences Inc. Financial Data Overview
Price chart is built with
Anychart
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Prev. Close
6.7519
Open
7.1506
High
7.1755
Low
6.6658
52 wk Range
3.42-7.3195
Market Cap
337 M
Shares Outstanding
49 964 K
Revenue
40 207 K
EPS
-0.96
Beta
0.43
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with TriSalus Life Sciences Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TriSalus Life Sciences Inc. data using free add-ons & libraries
Get TriSalus Life Sciences Inc. Fundamental Data
TriSalus Life Sciences Inc. Fundamental data includes:
- Net Revenue: 40 207 K
- EBITDA: -30 562 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.165
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TriSalus Life Sciences Inc. News
New
TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches
Earnings Call Insights: TriSalus Life Sciences (TLSI) Q3 2025 MANAGEMENT VIEW * CEO Mary Szela reported strong third quarter results, highlighting revenue of $11.6 million, a 57% increase year-ove...
TriSalus (TLSI) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, November 13, 2025 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Mary T. Szela Chief Financial Officer — David B. Patie...
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago. These figures ...
TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs
Earnings Call Insights: TriSalus Life Sciences (TLSI) Q2 2025 MANAGEMENT VIEW * CEO Mary T. Szela stated the company delivered $11.2 million in net sales for Q2 2025, marking a 52% year-over-year ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
